Heiko Schöder

Chief, Molecular Imaging and Therapy Service · New York Presbyterian Hospital

Credentials: · · · · ·

History

Molecular Imaging and Therapy Service Division · New York Presbyterian Hospital
Present

Theranostic DLL3/PSMA-Bi-Specific CAR-T Cells for Prostate Cancer Therapy
National Cancer Institute · R01
PI · $3.6M · Sloan-Kettering Inst Can Research
2024–2029
Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT
National Cancer Institute · U01
PI · $1.7M · Sloan-Kettering Inst Can Research
2012–2016

A Study of a New PET Scanner in People With Cancer
Principal investigator · Recruiting
Memorial Sloan Kettering Cancer Center
2026–2029
Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer
Principal investigator · Active not recruiting · Early phase 1
Memorial Sloan Kettering Cancer Center
2021–2026
Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer
Principal investigator · Active not recruiting
Memorial Sloan Kettering Cancer Center
2019–2027
Imaging With a PET Agent for Detection of Cancers of the Head and Neck
Principal investigator · Active not recruiting · Phase 1, Phase 2
Memorial Sloan Kettering Cancer Center
2018–2027